»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·áÁ¦ ½ÃÀåÀº 2024-2029³â µ¿¾È 8¾ï 2,590¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ µ¿¾È CAGR 6.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·áÁ¦ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ Æ÷ÇÔÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ÃËÁø¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ASDÀÇ À¯º´·ü Áõ°¡, ¹Î°ü ÆÄÆ®³Ê½ÊÀÇ Áõ°¡, ÀÚÆó½ºÆåÆ®·³Àå¾Ö¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡ µî¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ
2025³â
Á¾·á ¿¬µµ
2029
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³âºñ
6.4%
CAGR
6.9%
Áõ°¡¾×
8¾ï 2,590¸¸ ´Þ·¯
ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚµéÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÇâÈÄ ¸î ³â µ¿¾È ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ÀÌÀ¯ Áß Çϳª·Î ASD Ä¡·á¿¡¼ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀ» ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ Ä¡·áÁ¦ÀÇ ÀÌ¿ë È®´ë¿Í ASD¿¡ ´ëÇÑ È¿¼Ò´ëü¿ä¹ý(ERT)¿¡ ´ëÇÑ Å½±¸ Áõ°¡´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå Technavio ºÐ¼®
°¡°Ý¡¤¼ö¸íÁֱ⡤°í°´ ±¸ÀÔ ¹Ù½ºÄÏ¡¤Ã¤¿ë·ü¡¤±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå »óȲ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀå Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2024³â
½ÃÀå Àü¸Á 2024-2029³â
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·áÁ¦ ¼¼°è ½ÃÀå 2019-2023³â
À¯Åë ä³Îº° ºÎ¹® ºÐ¼® 2019-2023³â
À¯Çüº° ºÎ¹® ºÐ¼® 2019-2023³â
¿ëµµº° ºÎ¹® ºÐ¼® 2019-2023³â
Áö¿ªº° ºÎ¹® ºÐ¼® 2019-2023³â
±¹°¡º° ºÎ¹® ºÐ¼® 2019-2023³â
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : ÀÚÆó½ºÆåÆ®·³Àå¾Ö Ä¡·áÁ¦ ¼¼°è ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
±¸¸ÅÀÚÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô Âü¿©¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå »óȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : À¯Åë ä³Îº°
½ÃÀå ºÎ¹®
ºñ±³ : À¯Åë ä³Îº°
¼Ò¸Å ¾à±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
º´¿ø ¾à±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¿Â¶óÀÎ ¾à±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : À¯Åë ä³Îº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : À¯Çüº°
½ÃÀå ºÎ¹®
ºñ±³ : À¯Çüº°
°¢¼ºÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¼±ÅÃÀû ¼¼·ÎÅä´Ñ ÀçÈí¼ö ¾ïÁ¦Á¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Ç×Á¤½Åº´Á¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¼ö¸éÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : À¯Çüº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : ¿ëµµº°
½ÃÀå ºÎ¹®
ºñ±³ : ¿ëµµº°
ÀÚÆóÁõ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¾Æ½ºÆÛ°Å ÁõÈıº : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
±¤¹ü¼º ¹ß´Þ Àå¾Ö : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : ¿ëµµº°
Á¦11Àå °í°´ »óȲ
Á¦12Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ºÆäÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦13Àå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ, ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¡¤¾ïÁ¦¿äÀÎ
Á¦14Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
È¥¶õ »óȲ
¾÷°è ¸®½ºÅ©
Á¦15Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
AutismSTEP
Bristol Myers Squibb Co.
CureMark LLC
F. Hoffmann La Roche Ltd.
Fraser
Jazz Pharmaceuticals Plc
Les Laboratoires Servier
Neurim Pharmaceuticals Ltd.
Novartis AG
Oryzon Genomics SA
Otsuka Holdings Co. Ltd.
Q BioMed Inc.
Scioto Biosciences Inc.
Stalicla SA
Yamo Pharmaceuticals LLC
Á¦16Àå ºÎ·Ï
ksm
The autism spectrum disorder therapeutics market is forecasted to grow by USD 825.9 mn during 2024-2029, accelerating at a CAGR of 6.9% during the forecast period. The report on the autism spectrum disorder therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of asd, growing number of public-private partnerships, and growing awareness about autism spectrum disorders.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 6.4%
CAGR 6.9%
Incremental Value $825.9 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's autism spectrum disorder therapeutics market is segmented as below:
By Distribution Channel
Retail pharmacy
Hospital pharmacy
Online pharmacy
By Type
Stimulants
Selective serotonin reuptake inhibitors
Antipsychotic drugs
Sleep medications
Others
By Application
Autistic disorder
Asperger syndrome
Pervasive developmental disorder
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the increasing interest in personalized medicine for treatment of asd as one of the prime reasons driving the autism spectrum disorder therapeutics market growth during the next few years. Also, growing use of digital therapeutics and rise in exploration of enzyme replacement therapy (ERT) for asd will lead to sizable demand in the market.
The report on the autism spectrum disorder therapeutics market covers the following areas:
Autism Spectrum Disorder Therapeutics Market sizing
Autism Spectrum Disorder Therapeutics Market forecast
Autism Spectrum Disorder Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autism spectrum disorder therapeutics market vendors that include AutismSTEP, Bristol Myers Squibb Co., CureMark LLC, F. Hoffmann La Roche Ltd., Fraser, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Les Laboratoires Servier, Neurim Pharmaceuticals Ltd., Novartis AG, Oryzon Genomics SA, Otsuka Holdings Co. Ltd., Q BioMed Inc., Scioto Biosciences Inc., Stalicla SA, Travere Therapeutics Inc., and Yamo Pharmaceuticals LLC. Also, the autism spectrum disorder therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Autism Spectrum Disorder Therapeutics Market 2019 - 2023
Historic Market Size - Data Table on Global Autism Spectrum Disorder Therapeutics Market 2019 - 2023 ($ million)
5.2 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.3 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.4 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The impact of AI in the global autism spectrum disorder therapeutics market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Distribution Channel
8.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
8.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
8.3 Retail pharmacy - Market size and forecast 2024-2029
Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
8.4 Hospital pharmacy - Market size and forecast 2024-2029
Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
8.5 Online pharmacy - Market size and forecast 2024-2029
Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Type
9.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
9.3 Stimulants - Market size and forecast 2024-2029
Chart on Stimulants - Market size and forecast 2024-2029 ($ million)
Data Table on Stimulants - Market size and forecast 2024-2029 ($ million)
Chart on Stimulants - Year-over-year growth 2024-2029 (%)
Data Table on Stimulants - Year-over-year growth 2024-2029 (%)
9.4 Selective serotonin reuptake inhibitors - Market size and forecast 2024-2029
Chart on Selective serotonin reuptake inhibitors - Market size and forecast 2024-2029 ($ million)
Data Table on Selective serotonin reuptake inhibitors - Market size and forecast 2024-2029 ($ million)
Chart on Selective serotonin reuptake inhibitors - Year-over-year growth 2024-2029 (%)
Data Table on Selective serotonin reuptake inhibitors - Year-over-year growth 2024-2029 (%)
9.5 Antipsychotic drugs - Market size and forecast 2024-2029
Chart on Antipsychotic drugs - Market size and forecast 2024-2029 ($ million)
Data Table on Antipsychotic drugs - Market size and forecast 2024-2029 ($ million)
Chart on Antipsychotic drugs - Year-over-year growth 2024-2029 (%)
Data Table on Antipsychotic drugs - Year-over-year growth 2024-2029 (%)
9.6 Sleep medications - Market size and forecast 2024-2029
Chart on Sleep medications - Market size and forecast 2024-2029 ($ million)
Data Table on Sleep medications - Market size and forecast 2024-2029 ($ million)
Chart on Sleep medications - Year-over-year growth 2024-2029 (%)
Data Table on Sleep medications - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by Application
10.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
10.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
10.3 Autistic disorder - Market size and forecast 2024-2029
Chart on Autistic disorder - Market size and forecast 2024-2029 ($ million)
Data Table on Autistic disorder - Market size and forecast 2024-2029 ($ million)
Chart on Autistic disorder - Year-over-year growth 2024-2029 (%)
Data Table on Autistic disorder - Year-over-year growth 2024-2029 (%)
10.4 Asperger syndrome - Market size and forecast 2024-2029
Chart on Asperger syndrome - Market size and forecast 2024-2029 ($ million)
Data Table on Asperger syndrome - Market size and forecast 2024-2029 ($ million)
Chart on Asperger syndrome - Year-over-year growth 2024-2029 (%)
Data Table on Asperger syndrome - Year-over-year growth 2024-2029 (%)
10.5 Pervasive developmental disorder - Market size and forecast 2024-2029
Chart on Pervasive developmental disorder - Market size and forecast 2024-2029 ($ million)
Data Table on Pervasive developmental disorder - Market size and forecast 2024-2029 ($ million)
Chart on Pervasive developmental disorder - Year-over-year growth 2024-2029 (%)
Data Table on Pervasive developmental disorder - Year-over-year growth 2024-2029 (%)
10.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.13 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.16 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ million)
Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AutismSTEP
AutismSTEP - Overview
AutismSTEP - Product / Service
AutismSTEP - Key offerings
SWOT
15.5 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
15.6 CureMark LLC
CureMark LLC - Overview
CureMark LLC - Product / Service
CureMark LLC - Key offerings
SWOT
15.7 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
15.8 Fraser
Fraser - Overview
Fraser - Product / Service
Fraser - Key offerings
SWOT
15.9 Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc - Overview
Jazz Pharmaceuticals Plc - Product / Service
Jazz Pharmaceuticals Plc - Key news
Jazz Pharmaceuticals Plc - Key offerings
SWOT
15.10 Les Laboratoires Servier
Les Laboratoires Servier - Overview
Les Laboratoires Servier - Business segments
Les Laboratoires Servier - Key offerings
Les Laboratoires Servier - Segment focus
SWOT
15.11 Neurim Pharmaceuticals Ltd.
Neurim Pharmaceuticals Ltd. - Overview
Neurim Pharmaceuticals Ltd. - Product / Service
Neurim Pharmaceuticals Ltd. - Key offerings
SWOT
15.12 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.13 Oryzon Genomics SA
Oryzon Genomics SA - Overview
Oryzon Genomics SA - Product / Service
Oryzon Genomics SA - Key offerings
SWOT
15.14 Otsuka Holdings Co. Ltd.
Otsuka Holdings Co. Ltd. - Overview
Otsuka Holdings Co. Ltd. - Business segments
Otsuka Holdings Co. Ltd. - Key news
Otsuka Holdings Co. Ltd. - Key offerings
Otsuka Holdings Co. Ltd. - Segment focus
SWOT
15.15 Q BioMed Inc.
Q BioMed Inc. - Overview
Q BioMed Inc. - Product / Service
Q BioMed Inc. - Key offerings
SWOT
15.16 Scioto Biosciences Inc.
Scioto Biosciences Inc. - Overview
Scioto Biosciences Inc. - Product / Service
Scioto Biosciences Inc. - Key offerings
SWOT
15.17 Stalicla SA
Stalicla SA - Overview
Stalicla SA - Product / Service
Stalicla SA - Key offerings
SWOT
15.18 Yamo Pharmaceuticals LLC
Yamo Pharmaceuticals LLC - Overview
Yamo Pharmaceuticals LLC - Product / Service
Yamo Pharmaceuticals LLC - Key offerings
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations